McGrath RentCorp

McGrath RentCorp (Nasdaq: MGRC), relating to its proposed sale to WillScot Mobile Mini Holdings Corp. Under the terms of the agreement, MGRC shareholders will receive either $123.00 in cash or 2.8211 shares of WillScot per share they own.

California BanCorp

California BanCorp (NASDAQ: CALB), relating to its proposed merger with Southern California Bancorp. Under the terms of the agreement, California BanCorp shareholders will own approximately 42.9% of outstanding shares of the combined company.

AVROBIO, Inc.

AVROBIO, Inc. (Nasdaq: AVRO), relating to its proposed merger with Tectonic Therapeutic, Inc. Under the terms of the agreement, AVRO shareholders are expected to own approximately 22.3% of the combined company.

Science 37 Holdings, Inc.

Science 37 Holdings, Inc. (Nasdaq: SNCE), relating to its proposed sale to eMed, LLC. Under the terms of the agreement, SNCE shareholders will receive $5.75 in cash per share they own.

Haynes International, Inc.

Haynes International, Inc. (Nasdaq: HAYN), relating to its proposed sale to North American Stainless. Under the terms of the agreement, HAYN shareholders will receive $61.00 in cash per share they own.

Catalent, Inc.

Catalent, Inc. (NYSE: CTLT), relating to its proposed sale to Novo Holdings. Under the terms of the agreement, CTLT shareholders will receive $63.50 in cash per share they own.

Everbridge, Inc.

Everbridge, Inc. (Nasdaq: EVBG), relating to its proposed sale to Thoma Bravo. Under the terms of the agreement, EVBG shareholders will receive $28.60 in cash per share they own.

Battalion Oil Corp.

Battalion Oil Corp. (NYSE: BATL), relating to its proposed sale to Fury Resources, Inc. Under the terms of the agreement, BATL shareholders are expected to receive $9.80 in cash per share they own.

NuStar Energy L.P.

NuStar Energy L.P. (NYSE: NS), relating to its proposed sale to Sunoco LP. Under the terms of the agreement, NS shareholders are expected to receive 0.4 shares of Sunoco per share they own.

Inhibrx, Inc.

Inhibrx, Inc. (Nasdaq: INBX), relating to its proposed sale to Sanofi. Under the terms of the agreement, INBX shareholders are expected to receive $30.00 in cash and 0.25 shares of the newly combined company per share they own. Shareholders may also receive a plus one CVR worth up to $5.00 in cash contingent upon certain … Read more